Apolipoprotein E polymorphism interacts with cigarette smoking in progression of multiple sclerosis

• DOI: 10.1111/j.1468-1331.2009.02603.x
• Publication Date: 2009-03-26T16:55:36Z
• Authors: A. Sena; R. Couderc; V. Ferret-Sena; R. Pedrosa; M. L. Andrade; C. Araujo; R. Roque; M. J. Cascais; M. G. Morais
• Keywords: Adult; Multiple Sclerosis; Polymorphism, Genetic; Smoking; Middle Aged; Severity of Illness Index; 3. Good health; Disability Evaluation; 03 medical and health sciences; Apolipoproteins E; 0302 clinical medicine; CHLC NEU; Disease Progression; Humans; Female; Genetic Predisposition to Disease; 10. No inequality

The influence of apolipoprotein E (ApoE) polymorphism on clinical severity of multiple sclerosis (MS) is still controversial. Cigarette smoking has been suggested to influence the progression of disability in these patients. In this study, we aimed to investigate whether an interaction of smoking with the ApoE polymorphism influences the progression of disability in MS patients.Smoking history from 205 female patients with MS was obtained. Clinical data collected include age at onset, disease duration, annual relapse rate, the Expanded Disability Status Scale (EDSS) and the Multiple Sclerosis Severity Score (MSSS). ApoE polymorphism was examined in all patients and stratified according to smoking status and associations with the clinical data investigated.There were no significant associations between cigarette smoking and any of the clinical characteristics in the whole group of patients. In women carrying the ApoE E4 isoform, smokers had a lower EDSS (P = 0.033) and MSSS (P = 0.023) in comparison with non-smokers.Our data suggest that in women with MS carrying the ApoE E4 isoform, cigarette smoking may have a protective influence on disease progression and accumulation of disability. These findings need to be confirmed by future large longitudinal studies.